A detailed history of Cetera Investment Advisers transactions in Glaukos Corp stock. As of the latest transaction made, Cetera Investment Advisers holds 2,813 shares of GKOS stock, worth $402,090. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,813
Previous 3,687 23.7%
Holding current value
$402,090
Previous $436,000 16.06%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$113.62 - $135.39 $99,303 - $118,330
-874 Reduced 23.7%
2,813 $366,000
Q2 2024

Aug 22, 2024

SELL
$89.48 - $118.35 $72,747 - $96,218
-813 Reduced 18.07%
3,687 $436,000
Q1 2024

May 24, 2024

BUY
$76.4 - $96.33 $343,800 - $433,485
4,500 New
4,500 $424,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.8B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.